Viewing Study NCT04081103


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-02-25 @ 6:35 PM
Study NCT ID: NCT04081103
Status: TERMINATED
Last Update Posted: 2025-07-14
First Post: 2019-08-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Sponsor: Glaukos Corporation
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NEX-PED-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View